Open AccessComparative Effectiveness of Cloxacillin or Cefazolin Versus Vancomycin as Empiric Therapy in Patients With Methicillin-Susceptible Staphylococcus aureus (MSSA) Bacteremia
Author(s) -
Davie Wong,
Titus Wong,
Marc G. Romney,
Victor C. M. Leung
Publication year - 2015
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofv133.559
Subject(s) - cloxacillin , medicine , cefazolin , vancomycin , bacteremia , empiric therapy , staphylococcus aureus , microbiology and biotechnology , staphylococcal infections , antibiotics , penicillin , bacteria , biology , pathology , alternative medicine , genetics
Vancomycin as Empiric Therapy in Patients With Methicillin-Susceptible Staphylococcus aureus (MSSA) Bacteremia Davie Wong, MD; Titus Wong, MD, FRCPC; Marc G. Romney, MD, FRCPC, DTM&H; Victor Leung, MD, FRCPC; Infectious Diseases, University of British Columbia, Vancouver, British Columbia, Canada; Pathology and Laboratory Medicine, Vancouver Coastal Health, Vancouver, British Columbia, Canada; Pathology and Laboratory Medicine, Providence Health Care, Vancouver, British Columbia, Canada; Pathology and Laboratory Medicine, Infectious Diseases, Providence Health Care, Vancouver, British Columbia, Canada
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom